When was Nightingale founded?

Nightingale was founded in 2013 and raised its 1st funding round 6 years after it was founded.

Where is Nightingale located?

Nightingale is headquartered in Helsinki, Finland. It is registered at Rotermanni tn 14.

Which legal entities is Nightingale associated with?

Nightingale is associated with Nightingale Health Estonia OÜ.

How many employees does Nightingale have?

As of Jun 30, 2026, the latest employee count at Nightingale is 139.

Is Nightingale a funded company?

Nightingale is a funded company, having raised an undisclosed amount across 3 funding rounds to date. The company's 1st funding round was a $***** Conventional Debt round, raised on Jan 22, 2019.

When was the latest funding round of Nightingale?

Nightingale's latest funding was a $***** Grant (prize money) round on Jan 01, 2021, with participation from 1 investor. Its primary sector is Healthcare IT. Globally, the Healthcare IT sector has seen $8.41B in funding in 2026 to date.

Where does Nightingale rank among its competitors?

Nightingale ranks 2nd amongst 71 active competitors, of which 10 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was PREVIA, which secured $2.25M in Feb, 2023.

Who are the top competitors of Nightingale?

Nightingale's top competitors include KenSci, BaseHealth and UCARE.AI. Among them, PREVIA secured the most recent funding round in February, 2023.

Nightingale - 2026 Company Profile, Funding, Competitors & Financials

Nightingale is a public company based in Helsinki (Finland), founded in 2013. It operates as a Provider of a metabolomic technology platform for blood analysis and research. Nightingale has raised an undisclosed amount in funding from Mitsui and Kirin Holdings. The company has 71 active competitors, including 10 funded and 7 that have exited. Its top competitors include companies like KenSci, BaseHealth and UCARE.AI.

Company Details

Provider of a metabolomic technology platform for blood analysis and research. The company has proprietary mass-scale blood analysis technology the company has developed disease detection tests. The platform utilizes NMR spectroscopy to directly measure 220 metabolites in the blood sample to look for signatures indicative of diseases such as diabetes and cardiovascular disease. The company's platform can also be used for biomarker discovery to develop new tests.

Website: nightingalehealth.com
Social
Email ID: *****@nightingalehealth.com, *****@nightingalehealth.com
Registered Address: Rotermanni tn 14

Key Metrics

Founded Year

2013

Location

Helsinki, Finland

Stage

Public

Latest Funding Round

Grant (prize money), Jan 01, 2021, $*****

Investors

Mitsui & 6 more

Ranked

2^nd among 71 active competitors

Employee Count

139 as on Jun 30, 2026

Investment & Acquisitions

Welltus & 1 more

Similar Companies

KenSci & 91 more

Exit Details

Public

View Nightingale's full profile

Nightingale is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Nightingale Health Estonia OÜ CIN: 16507787 , Estonia, Active	May 25, 2022	-	1 (As on Sep 30, 2024)

Nightingale got listed on Mar 19, 2025.

Click here to take a look at Nightingale's IPO in detail

Nightingale has raised funding over 3 rounds. Its first funding round was on Jan 22, 2019. Its latest funding round was a Grant (prize money) round on Jan 01, 2021 for $*****. 1 investor participated in its latest round. Nightingale has 7 institutional investors.

Here is the list of recent funding rounds of Nightingale:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2021	9453109	Grant (prize money)	4775049	7663761	8477060	8385869
Dec 02, 2019	8405752	Seed	8762244	8939629	5075590	3364963
Jan 22, 2019	1684761	Conventional Debt	5539268	6926916	2861377	European Investment Bank

Access funding benchmarks and valuations. Sign up today!

View details of Nightingale's funding rounds and investors

Nightingale's employee count trend

Nightingale has 139 employees as of Jun 26. Here is Nightingale's employee count trend over the years:

Uncover Nightingale's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nightingale include KenSci, BaseHealth and UCARE.AI. Here is the list of Top 10 competitors of Nightingale, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	KenSci 2015, Seattle (United States), Acquired	Machine learning based predictive analytics platform for risk prediction to healthcare providers	$30.5M	Polaris Partners, Ignition Partners & 5 others	52/100
2nd	Nightingale 2013, Helsinki (Finland), Public	Provider of a metabolomic technology platform for blood analysis and research	-	European Investment Bank, Mitsui & 5 others	42/100
3rd	BaseHealth 2011, Redwood City (United States), Acquired	Personalized health management platform driven by genomics	$17.5M	HBM Healthcare Investments, RONA Holdings ... & 6 others	41/100
4th	UCARE.AI 2016, Singapore (Singapore), Series A	AI-based disease prediction solution for healthcare professionals	-	Walden International, Plug and Play APAC ... & 15 others	40/100
5th	RetinaRisk 2013, Reykjavik (Iceland), Seed	Provider of decision support system for point of care risk assessment for diabetes retinopathy	$1.8M	Iceland Venture Studio	39/100
6th	ToLife 2009, Belo Horizonte (Brazil), Series B	Provider of emergency care management software for hospitals	$3.5M	VOX Capital, Endeavor & 2 others	39/100
7th	Advance Health 2010, Chantilly (United States), Acqui-Hired	Provider of health risk assessments and care management solutions for providers	$40M	Summit Partners, HarbourVest Partners & 2 others	37/100
8th	PeraHealth 2008, Charlotte (United States), Acquired	Patient condition tracking solutions for hospital patient care applications with real time feedback	$15.3M	Mainsail Partners, Mertz Holdings & 1 others	37/100
9th	Peach IntelliHealth 2013, New York City (United States), Seed	Provider of AI based platform to predict patient trajectory	$414K	TNF Ventures, Plug and Play APAC	37/100
10th	PREVIA 2020, Rhone Alpes (France), Seed	Provider of AI-based software for data management	$2.25M	BNP Paribas, UI Investissement & 7 others	37/100